🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Travere Therapeutics, Inc.

Travere Therapeutics, Inc. logo
Market Cap: Medium
Employees: Medium

Chenodal, Cholbam, Thiola, Sparsentan, TVT-058

Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.

Tags: Chenodal, Cholbam, Sparsentan, TVT-058, Thiola, biopharmaceutical, rare diseases, therapeutics

Symbol: TVTX

Recent Price: $17.32

Industry: Biotechnology

CEO: Dr. Eric M. Dube Ph.D.

Sector: Healthcare

Employees: 380

Address: 3611 Valley Centre Drive, San Diego, CA 92130

Phone: 888 969 7879

Leadership

  • Eric Dube, Ph.D., President & Chief Executive Officer
  • Chris Cline, CFA, Chief Financial Officer
  • Angela Giannantonio, Senior Vice President, Human Resources
  • Peter Heerma, Chief Commercial Officer
  • Jula Inrig, M.D., Chief Medical Officer
  • Casey Logan, Chief Business Officer
  • Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
  • William Rote, Ph.D., Senior Vice President, Research & Development
  • Charlotte Smith, Senior Vice President, Public Affairs
  • Gary A. Lyons, Chairman
  • Roy D. Baynes, M.D., Ph.D.,
  • Suzanne L. Bruhn, Ph.D.,
  • Tim Coughlin, CPA,
  • Jeffrey A. Meckler,
  • John A. Orwin,
  • Sandra E. Poole,
  • Ron Squarer,
  • Ruth Williams-Brinkley, FACHE,

Last updated: 2024-12-31